Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22544,1738,1.23 [1.14-1.32],4.0223489481886046e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Candidiasis,22823,540,1.15 [1.01-1.31],0.0306582177790625
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22077,4192,1.15 [1.10-1.21],2.6684432410652753e-09
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22027,4275,1.22 [1.17-1.28],5.75844886178015e-17
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,20028,1291,1.19 [1.09-1.29],8.02622360230133e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,19325,1575,1.29 [1.20-1.40],6.160553590648479e-11
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,18827,338,1.30 [1.10-1.53],0.0021406498605631
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,14837,2721,1.20 [1.13-1.27],8.33298507412353e-10
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,18770,497,1.45 [1.26-1.66],1.1171257240015428e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22799,1678,1.09 [1.01-1.17],0.0270757621298019
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Mycoses,22917,634,1.15 [1.02-1.30],0.0226804409904419
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22036,1230,1.25 [1.15-1.36],3.263352458615388e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,22848,1427,1.16 [1.07-1.25],0.0004134671041331
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,22666,1245,1.15 [1.05-1.25],0.0019299259107967
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",22887,118,1.34 [1.02-1.77],0.0366682292508977
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21300,494,1.28 [1.12-1.47],0.0004274456133614
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,22962,50,1.81 [1.18-2.78],0.0067319004290373
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],22818,78,1.45 [1.03-2.04],0.0329921516561503
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,22936,434,0.85 [0.73-0.98],0.0256897152592415
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Descending colon,22932,254,0.79 [0.66-0.96],0.0158034574121796
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,22919,536,0.86 [0.75-0.98],0.0245325175886488
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,16463,144,0.64 [0.51-0.81],0.0002426611382201
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",17801,1482,0.90 [0.83-0.98],0.0106018788354167
PLA2G10,Group 10 secretory phospholipase A2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",17880,1561,0.90 [0.84-0.98],0.0102568030032096
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,20666,162,1.44 [1.13-1.83],0.0027824952094304
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22349,70,1.45 [1.01-2.07],0.0439064482960201
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22221,3491,1.19 [1.13-1.25],3.2782833521959635e-11
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22466,1962,1.17 [1.10-1.26],4.221634116008824e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22464,1960,1.17 [1.10-1.26],4.686985902025824e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22618,1428,1.32 [1.22-1.43],1.1312459245187813e-11
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,22797,357,1.41 [1.20-1.66],2.3735651712355847e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",22732,292,1.37 [1.15-1.64],0.0004938661017373
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,15356,412,1.31 [1.13-1.53],0.0003975829427653
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21478,103,0.72 [0.52-0.98],0.0395015508097296
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21489,114,0.61 [0.46-0.81],0.0005846636151224
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",22187,954,1.22 [1.11-1.35],6.790299200079069e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,15309,365,1.34 [1.14-1.57],0.0003399621843585
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,15205,261,1.24 [1.03-1.50],0.0230665891884618
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,15652,708,1.20 [1.07-1.35],0.0015249403955027
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,22915,367,1.29 [1.11-1.51],0.0012512594301044
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,22708,160,1.37 [1.08-1.73],0.0092614696924719
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,15324,380,1.51 [1.30-1.77],1.5092917281581764e-07
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,15369,425,1.22 [1.05-1.41],0.0094519626221802
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,15123,179,1.50 [1.19-1.88],0.0004870464639894
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,22698,150,1.39 [1.09-1.77],0.0077592740937995
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,15833,889,1.32 [1.19-1.47],7.700858978991655e-08
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,15601,657,1.13 [1.01-1.28],0.036406668162748
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21339,6395,1.05 [1.01-1.09],0.0075719332921985
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",17173,2229,1.25 [1.17-1.33],1.0250302371197578e-11
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,22960,312,1.84 [1.55-2.18],1.7267742009609209e-12
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20188,181,2.19 [1.75-2.73],3.2046011558709024e-12
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2463,98,1.67 [1.23-2.25],0.0008668063765855
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2634,311,1.43 [1.21-1.69],2.5086462848354604e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,20091,84,2.19 [1.56-3.08],5.502034178199239e-06
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2437,75,1.93 [1.37-2.72],0.0001551204368294
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22137,2130,1.07 [1.01-1.15],0.033839207560711
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,16052,1108,1.20 [1.09-1.31],0.0001298586092167
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",22840,299,1.28 [1.08-1.53],0.0051177039304684
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),21495,268,1.22 [1.01-1.48],0.0364569457314055
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,21598,371,1.18 [1.00-1.38],0.0455838632869763
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11609,2796,1.10 [1.04-1.17],0.0011794398829302
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,AV-block,17470,677,1.27 [1.13-1.43],8.53885220914287e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Cardiac arrest,9080,267,1.56 [1.29-1.89],3.85292774148991e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Conduction disorders,18339,1546,1.23 [1.14-1.33],1.3840644894485486e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21416,329,1.30 [1.10-1.53],0.0023166293947146
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22686,1648,1.25 [1.16-1.34],8.221205708066535e-09
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",22807,92,1.50 [1.09-2.07],0.0118687224855265
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12065,258,1.43 [1.18-1.73],0.0002936045629606
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12014,207,2.10 [1.70-2.60],1.0642117973733535e-11
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Hypotension,22792,1641,1.26 [1.17-1.35],2.294715228214132e-09
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22460,797,1.13 [1.02-1.26],0.0222501752877932
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,17316,523,1.16 [1.02-1.33],0.0282436463811409
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Oesophageal varices,21152,65,1.49 [1.02-2.17],0.0385489808369239
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other arrhythmias,17382,589,1.16 [1.02-1.32],0.0206893459702199
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21554,327,1.25 [1.05-1.47],0.0103766870666995
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,21268,181,1.35 [1.08-1.68],0.0088720647267758
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,18247,1454,1.21 [1.11-1.31],4.323454055906308e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,21214,63,1.54 [1.05-2.26],0.0260816021918284
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,21952,725,1.24 [1.11-1.39],0.0001834687766501
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22199,522,1.43 [1.26-1.63],9.092870676803385e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",21811,973,1.16 [1.06-1.28],0.0023541934703044
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,9230,417,1.24 [1.07-1.45],0.0046910337688222
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,21785,593,1.22 [1.08-1.39],0.0014195280281847
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),21503,416,1.26 [1.09-1.46],0.0022954066023136
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22280,603,1.19 [1.05-1.35],0.0055550753111318
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,22875,965,1.17 [1.06-1.29],0.0013455186135793
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,17301,508,1.35 [1.17-1.54],2.110633936760789e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22192,515,1.43 [1.26-1.64],9.95439695309325e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,21099,261,1.23 [1.02-1.49],0.0300911817581754
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22445,909,1.12 [1.01-1.24],0.0292735497998848
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Varicose veins,21600,513,1.20 [1.05-1.37],0.0084486583659372
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,22696,943,1.22 [1.11-1.35],6.453633735860842e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",22894,332,0.74 [0.63-0.87],0.0004182599003384
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19619,1378,1.10 [1.01-1.19],0.0273321843553915
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",22866,392,0.73 [0.63-0.85],7.442770380366023e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Vascular dementia,22083,233,1.27 [1.04-1.55],0.0197864937981828
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,22898,411,1.17 [1.01-1.36],0.0383720979377251
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22519,1348,1.15 [1.06-1.25],0.0007220633537844
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,22920,915,1.12 [1.02-1.24],0.0231488944166667
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22320,3435,1.14 [1.08-1.20],5.585924913733519e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Generalized epilepsy,22598,53,1.93 [1.28-2.91],0.0016909544831533
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Hemiplegia,22822,335,1.24 [1.05-1.46],0.0110122128891368
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Neurological diseases,21498,4330,1.07 [1.02-1.12],0.0027115247440734
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,22374,320,1.23 [1.04-1.46],0.0177401840705975
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",22894,351,1.36 [1.16-1.60],0.000197307729555
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,17181,968,1.14 [1.04-1.26],0.0072840148503617
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Other sleep disorders,21684,513,1.20 [1.05-1.37],0.0084344476361731
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Sleep apnoea,22744,436,1.16 [1.00-1.34],0.0443673307775022
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,22604,61,1.93 [1.31-2.85],0.0009579943207271
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),22024,227,1.28 [1.04-1.56],0.0188097116935179
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,22718,268,1.77 [1.47-2.12],9.289330119862335e-10
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2441,76,2.02 [1.44-2.84],4.527959130256845e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,3014,112,1.70 [1.28-2.24],0.0001992402769903
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22680,1421,1.18 [1.09-1.28],3.965781520708666e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20530,3226,1.12 [1.06-1.18],4.3514977398820574e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,22958,188,1.33 [1.07-1.66],0.0115830406557412
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,20027,2723,1.12 [1.06-1.19],0.0001068640209509
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,All influenza,20304,159,1.80 [1.42-2.29],1.551133419244843e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),20301,156,1.78 [1.40-2.27],2.7963551470020664e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Bronchiectasis,19250,510,1.38 [1.21-1.58],2.5398448779638382e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,21857,3117,1.09 [1.03-1.15],0.0021818380291805
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22684,1625,1.18 [1.09-1.27],2.472256703404836e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,20843,6094,1.09 [1.05-1.14],1.0828528211294537e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Early onset COPD,21166,107,1.50 [1.12-2.01],0.00658624551854
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Emphysema,19172,432,1.36 [1.17-1.57],4.556855953625163e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21676,449,1.82 [1.58-2.10],1.6425701147324532e-16
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22714,2569,1.19 [1.12-1.27],7.742303445593156e-09
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Interstitial lung disease,21718,491,1.80 [1.57-2.06],3.1568129850905984e-17
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Later onset COPD,22456,1518,1.16 [1.07-1.25],0.0002929543889087
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,22956,495,1.18 [1.03-1.35],0.0201682956699765
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22694,1292,1.36 [1.25-1.48],6.565721170027084e-13
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other diseases of pleura,22682,2677,1.13 [1.07-1.20],2.54062457749104e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,22855,587,1.67 [1.47-1.89],7.942858682893304e-16
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,22842,1712,1.09 [1.01-1.17],0.0258855883252961
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pleural effusion,21363,1358,1.17 [1.08-1.28],0.000136674187869
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pleural plaque,20259,254,1.30 [1.07-1.58],0.0078504998945328
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22428,2283,1.19 [1.12-1.27],5.560119877537996e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,22849,388,1.20 [1.03-1.41],0.0189254642728149
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22670,1268,1.38 [1.27-1.50],1.0804450443743836e-13
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Viral pneumonia,20445,300,1.27 [1.06-1.51],0.0091240178353567
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",20886,144,1.39 [1.08-1.79],0.011555542148518
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",22552,144,1.37 [1.07-1.77],0.0139615441120218
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",22837,122,1.52 [1.16-2.01],0.0026085549135592
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Coeliac disease,21233,128,1.84 [1.41-2.40],7.161824946226665e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Collagenous colitis,21227,100,1.39 [1.03-1.88],0.0331135013393839
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Constipation,22690,2119,1.09 [1.02-1.17],0.0078302317117204
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,19852,2540,1.09 [1.03-1.16],0.0036068309686088
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20423,4563,1.09 [1.04-1.14],0.0001158914120591
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22639,471,1.16 [1.01-1.33],0.0400135393456203
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22259,91,1.60 [1.17-2.19],0.0036194240424882
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22634,1529,1.18 [1.10-1.28],2.132372245467311e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22082,143,1.53 [1.19-1.97],0.0009743365382397
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastric ulcer,16285,425,1.30 [1.12-1.50],0.0005351639116861
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18515,2655,1.07 [1.01-1.13],0.0322471681369391
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,16511,651,1.24 [1.10-1.40],0.0004359054623854
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,GI-bleeding,22375,1270,1.16 [1.06-1.26],0.0008487713467066
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Hernia,20935,3623,1.05 [1.00-1.11],0.0410561247528115
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,21252,147,1.82 [1.42-2.34],2.243980022400129e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Oesophagitis,16546,686,1.14 [1.02-1.28],0.0245700721456434
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,16626,766,1.14 [1.02-1.28],0.0187991573169743
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,16950,1090,1.10 [1.00-1.21],0.0426054581266233
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22391,1286,1.17 [1.07-1.27],0.0004238434848689
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,16635,2164,1.09 [1.02-1.16],0.0115881172271728
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18003,2143,1.14 [1.07-1.22],5.8958549694511054e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22048,109,1.47 [1.10-1.96],0.0094919711075705
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21259,132,1.39 [1.07-1.81],0.0147323306559236
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22342,821,1.18 [1.06-1.31],0.0018394216674648
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,20887,631,1.44 [1.27-1.62],4.074651155506162e-09
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21371,3712,1.12 [1.07-1.18],8.418721885981049e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22586,1065,1.20 [1.10-1.32],9.6406274284242e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,20314,58,1.88 [1.28-2.75],0.0011959624068263
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,21751,230,1.56 [1.28-1.91],1.1101930615778087e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,22767,224,1.29 [1.05-1.58],0.013689914376578
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22411,96,1.68 [1.23-2.28],0.0009461450448159
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,20333,77,1.49 [1.05-2.10],0.0251321376137583
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22361,2105,1.18 [1.10-1.26],1.9240256665962924e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,22880,337,1.20 [1.02-1.42],0.0280400206930405
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,20378,122,0.75 [0.58-0.98],0.0368554828662207
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",20594,338,1.68 [1.42-1.97],6.279003755288731e-10
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,19052,145,1.30 [1.01-1.67],0.044101636500679
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,19097,190,1.28 [1.03-1.60],0.0264311570512547
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",22762,245,1.26 [1.04-1.53],0.0179547923368649
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,19484,577,1.16 [1.02-1.31],0.0224868731762601
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18580,7985,1.04 [1.00-1.07],0.0413730014363299
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22039,3132,1.10 [1.04-1.16],0.000537760432605
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,15834,2000,0.92 [0.86-0.98],0.0149916149849458
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,18987,80,1.71 [1.22-2.39],0.0018716422161432
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,20405,85,1.74 [1.25-2.42],0.0009525653722327
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22542,2222,1.19 [1.12-1.27],6.311399268199244e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,21888,1568,1.21 [1.12-1.31],7.497140949731551e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,20825,505,1.29 [1.13-1.47],0.0002118038675884
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",20884,1977,1.11 [1.04-1.19],0.0029356433936477
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20399,1344,1.09 [1.00-1.18],0.0487782615939753
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,19103,196,1.31 [1.05-1.62],0.0145578097761533
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,19565,658,1.21 [1.08-1.37],0.0012187694919073
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17859,881,1.13 [1.02-1.25],0.0173239461443116
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,19698,643,1.17 [1.04-1.32],0.0100488725276136
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14668,834,1.11 [1.00-1.24],0.0464903498246719
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,19190,283,1.28 [1.07-1.53],0.0079121812272273
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,20905,1998,1.09 [1.02-1.17],0.0087202280811299
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20215,1308,1.13 [1.04-1.23],0.0048166212437241
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22238,115,1.45 [1.10-1.91],0.0078856367619903
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,21475,2246,1.32 [1.23-1.40],5.077069077371504e-17
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21547,2318,1.46 [1.37-1.56],3.113457899098382e-32
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,22738,128,1.91 [1.47-2.48],1.2666461503880914e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Dialysis,19326,97,2.13 [1.56-2.90],1.5975954087906545e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10103,2136,1.08 [1.01-1.16],0.0184168684420319
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18925,6268,1.09 [1.05-1.13],8.189070794385107e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,22706,96,2.21 [1.63-3.01],3.712213076559388e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Hydrocele,8082,115,1.36 [1.02-1.82],0.0357430866212816
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9784,1817,1.11 [1.03-1.19],0.0055896055446916
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,18914,85,1.52 [1.10-2.11],0.0119481980458441
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,21775,2946,1.10 [1.04-1.17],0.0006318191222782
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,11714,51,0.67 [0.46-0.97],0.0328567268837109
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21176,2347,1.15 [1.08-1.23],1.0529660033481294e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9257,66,0.71 [0.51-1.00],0.0475311854325392
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9330,139,0.78 [0.61-0.99],0.043842438560057
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22685,3736,1.28 [1.21-1.34],7.115512433680037e-22
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",19044,95,1.52 [1.12-2.08],0.0080652911718801
